Delivery Order SPE2DB22D2211-SPE2DB25FSAET
Award Date 7/3/25
Potential Completion Date 7/7/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,196.02 to AmerisourceBergen Drug Corp for 4,568,895,450 units of Actemra 400 mg/20 mL vials on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract utilizes firm fixed pricing with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,123.36 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX) valued at $999.99 billion and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,616.62 to AmerisourceBergen Drug Corp for Actemra 162 mg/0.9 mL syringes on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The place of...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Actemra 162 mg/0.9 mL syringes. This non-competitive, firm fixed-price delivery order carries a ceiling value of $15,381.06 with an ultimate completion date of September 8, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Actemra 400 mg/20 ml vials, with a contract ceiling value of $3,788.05 and an ultimate completion date of November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this...
- The Defense Logistics Agency (DLA) awarded a $15,029.42 delivery order to AmerisourceBergen Drug Corp for Actemra 400 mg/20 ml vials on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-set-aside, firm fixed price contract represents a single delivery order for a pharmaceutical product to be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $20,188.75 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed price, non-set-aside contract with a completion date of September 22, 2025, and performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,295.36 to AmerisourceBergen Drug Corp for the supply of ACTEMRA 200 mg/10 mL vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9M through December 2026. The delivery order was awarded on July 30, 2025, with a completion date of July 31, 2025, and will be performed at...
- The Defense Logistics Agency awarded a $8,243.54 delivery order to AmerisourceBergen Drug Corp for 4,569,930,973 units of Actemra 400 mg/20 ml vials. This is a non-set-aside, competitively awarded firm fixed-price delivery order with a completion date of November 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $13,171.30 delivery order to AmerisourceBergen Drug Corp for 4,568,832,740 units of Actemra 400 mg/20 mL vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued...